Evidence map›Paper›PMID 39653658›Full record

ArticleInternational journal of cancer2025

Associations of chronic liver disease and liver cancer with glyphosate and its metabolites in Thailand.

Daxesh P Patel, Christopher A Loffredo, Benjarath Pupacdi, Siritida Rabibhadana, Panida Navasumrit, Jittiporn Chaisaingmongkol, Leila Toulabi, Majda Haznadar, Bhavik Dalal, Mohammed Khan and 16 more

Abstract read
In one paragraph

Article in International journal of cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Daxesh P PatelLaboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.ORCID https://orcid.org/0000-0002-9620-8660
Christopher A LoffredoGeorgetown University Medical Center, Washington, DC, USA.
Benjarath PupacdiChulabhorn Research Institute, Bangkok, Thailand.
Siritida RabibhadanaChulabhorn Research Institute, Bangkok, Thailand.
Panida NavasumritChulabhorn Research Institute, Bangkok, Thailand.
Jittiporn ChaisaingmongkolChulabhorn Research Institute, Bangkok, Thailand.
Leila ToulabiLaboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
Majda HaznadarLaboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
Bhavik DalalLaboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
Mohammed KhanLaboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
Joshua StoneLaboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
Vajarabhongsa Bhudhisawasdi *Chulabhorn Research Institute, Bangkok, Thailand.
Nirush LertprasertsukeChiang Mai University, Chiang Mai, Thailand.
Anon ChotirosniramitChiang Mai University, Chiang Mai, Thailand.
Chawalit PairojkulKhon Kaen University, Khon Kaen, Thailand.
Chirayu U AuewarakulChulabhorn Hospital, Bangkok, Thailand.
Thaniya SricharunratChulabhorn Hospital, Bangkok, Thailand.
Kannika PhornphutkulRajavej Hospital, Chiang Mai, Thailand.
Suleeporn SangrajrangNational Cancer Institute, Bangkok, Thailand.
Anuradha BudhuLaboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
Chulabhorn MahidolChulabhorn Research Institute, Bangkok, Thailand.
Xin W WangLaboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.ORCID https://orcid.org/0000-0001-9735-606X
Frank J GonzalezLaboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Mathuros RuchirawatChulabhorn Research Institute, Bangkok, Thailand.
Curtis C HarrisLaboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
TIGER‐LC Consortium

Funding

Precision Medicine of CancerZIABC011492 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HARRIS, CURTIS · 2013 to 2025
$23.2M
Molecular signatures for liver cancer diagnosis and treatment stratificationZ01BC010313 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI WANG, XIN WEI · 1999 to 2008
$1.8M
Intramural NIH HHS Z01 BC010313Intramural NIH HHS ZIA BC011492Intramural research program of the Center for Cancer Research, National Cancer Institute of the United States Z01BC010313Thailand Science Research and Innovation (TSRI), Chulabhorn Research Institute 49890/4759784
6 · The paper itself

Abstract

Glyphosate [N-(phosphonomethyl) glycine], a systemic herbicide, is used globally (825 million kg/year) in 750+ formulations. The International Agency for Research on Cancer classified glyphosate is a probable human carcinogen (Group 2A), but epidemiological studies have been lacking for its association with liver cancer and chronic liver disease. We analyzed urine specimens from 591 patients with newly diagnosed liver cancer, chronic liver disease (CLD), and healthy individuals from five different medical centers between 2011 to 2016 in Thailand. Gas chromatography electrospray ionization mass spectrometry (GC-ESI/MS) was used to quantify glyphosate and its metabolites, aminomethylphosphonic acid (AMPA) and phosphoric acid (PPA) to study their levels in urine of hepatocellular carcinoma (HCC) and CLD patients in comparison to matched healthy individuals. Significantly higher levels of glyphosate were found in CLD patients compared to HCC cases and hospital controls, while significantly elevated levels of both AMPA and PPA were observed in HCC and CLD patients compared to hospital controls. Glyphosate and its metabolites were also detected at low to moderately high levels in convenience samples of food products and drinking water. These results raise concerns about the potential role of glyphosate in chronic liver disease and liver cancer risk.

Indexed as

Carcinoma, HepatocellularGlycineHerbicidesLiver DiseasesLiver NeoplasmsAdultAgedCase-Control StudiesChronic DiseaseFemaleGlyphosateHumansMaleMiddle AgedOrganophosphonatesPhosphoric Acidsaminomethylphosphonic acid (AMPA)GlycineGlyphosateHerbicidesOrganophosphonatesphosphoric acidPhosphoric Acidschronic liver diseaseenvironmental carcinogensglyphosatehepatocellular carcinomahospital‐based case control study

Identifiers

PMID39653658
PMCPMC11924304

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.